Objectives: With strides in life expectancy, more people with CF are choosing parenthood. However, CF remains a life-limiting condition, raising health and social issues. We developed a parenthood pathway based on needs identified at Annual Review with the key aims: improve information for patients considering parenthood; ensure individualised pre-pregnancy counselling and joint obstetric care plans; facilitate hospital stays following birth. Results: 1. Bristol Adult CF Centre developed www.cfinfo.org, an open access free resource for CF centres and patients; ensuring they have the information they need to make the right choices. The website includes medical aspects; genetics; diet; physiotherapy; psychosocial aspects of parenthood and chronic disease, fertility treatment and end of life. Developed in collaboration with patients who contributed filmed interviews, it facilitates pregnancy and parenthood discussions. With excellent feedback from patients and other CF centres, it is endorsed by the CF Trust, linked through their website; patients from all centres are encouraged to contribute. Since going live 'hits' are steadily increasing with the majority revisiting. 2. Shared CF-Maternal Medicine care plans are now held electronically. Including obstetric reviews, physiotherapy and social support, these have improved care and communication between teams and patients. 3. Facilities for newborn baby and partner in 'Mother and baby' cubicle to support new mothers requiring admission, improving treatment adherence. Conclusion: The pathway and website help address key issues facing people with CF and support longterm care.
Objectives:
The nontuberculous mycobacterium (NTM) Mycobacterium abscessus (MABSC) is now thought to be frequently transmitted between individuals with CF despite conventional cross-infection measures [1] . New national NTM guidelines have been developed to enhance infection control although their psychological impact on patients is unknown. Since other infection control measures may result in feelings of stigmatisation, isolation, and loss [2−4] , we wanted to explore patient experience at one centre following implementation of NTM guidelines to inform ongoing service development and strategies to minimise psychological distress. Method: Adult CF patients attending Papworth Hospital with positive cultures for MABSC were asked to complete a questionnaire about their experiences of changes to their care, with a subgroup interviewed to obtain in-depth qualitative information. Results: Results to date indicate that patients value information provision and the opportunity to discuss concerns with members of the multi-disciplinary team. Several reported psychological distress and have suggested ways to make the changes more acceptable. These include enhancing clarity surrounding the changes, achieving greater equality of services, and improving communication and information provision.
Conclusions:
We anticipate that the results will allow us to minimise potential psychological distress when implementing new infection control measures. We hope that this exploratory study will inform further research about supporting this group of patients. Objectives: As survival of people with CF continues to improve, they are increasingly likely to be placed in the position of having to act as carer for their parents and other older relatives. However there is currently no evidence as to the prevalence of this situation and the implications. We therefore conducted a prospective pilot study aiming to assess the impact that caring for an older family member has on CF patients' mental and physical health.
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Methods:
We approached patients that we had already identified as carers and asked them to complete a questionnaire. The survey asked their age and gender; which family member they had cared for and why; whether their own health had suffered as a consequence; how acting as a carer had made them feel (scored on VAS, 1=mild to 10=severe) and whether they felt they needed more support. Results: We have currently recruited 5 patients (1 male, median age 48 yrs), who had acted as carer for 9 older relatives (7 parents, 1 mother-in-law, 1 grand-parent). Patients had acted as carer for (median) 17 yrs, 15.5 hrs/wk. 4/5 felt that this had adversely impacted on their own health. Caring had resulted in the following emotions: stress (median severity 10/10), anxiety (8/10), isolated (6/10), depressed (7/10), resentful (8/10) and angry (7/10). 3/5 felt that they needed more support at home. Conclusion: People with CF find that caring for older relatives is physically and emotionally challenging and that this adversely impacts on their own health. These patients are likely to need additional support and this should be considered as part of holistic CF care. Objectives: Despite rising numbers of children born to mothers with CF, there are almost no data about the life experience of these women. Therefore, we aimed to explore both CF-specific as well as generic aspects of motherhood with CF. Methods: Cross-sectional, mixed-methods study (qualitative and quantitative measures); the present part of the study is based on data assessed with a purposedesigned questionnaire. Sample: 73 women were informed by their local CF centre. Of these, 44 were willing to participate and 38 actually enrolled. Participants were on average 33±7.1 y. Results: Most of the women had given birth to one child, six women to 2 children and three even to 3 children. Mean age of first-born child was 6.9 y (0.9 y to 25 y). At birth, 11% of mothers were less than 20 y. Pregnancy was unplanned in 24% of women and initial reactions of significant others were frequently mixed, with own parents reacting less positive than partners or other significant others. Knowledge about 'pregnancy and CF' was modest in most cases, both regarding a possible impact of CF on pregnancy and a possible impact of pregnancy on the course of CF. At the end of child's first year 68% of mothers stated that their new role was as easy as or easier than they had expected. Conclusion: Motherhood is increasingly becoming common in women with CF. Therefore, further information about their life experience is needed to enable comprehensive counselling as requested. Supported by Novartis Pharma GmbH, Germany.
